Accession Number: | 0001127602-22-013206 |
Date: | 2022-05-02 |
Issuer: | HAEMONETICS CORP (HAE) |
Original Submission Date: |
DARECCA JAMES
125 SUMMER STREET
BOSTON, MA 02110
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2022-05-02 | A | 5,902 | a | $0.00 | 5,902 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) | 50.83 | 2022-05-02 | deemed execution date | A | 13,828 (a) | 2029-05-02 | common stock 13,828 | $50.83 | 13,828 | direct |
ID | footnote |
---|---|
f1 | the securities awarded are in the form of restricted stock units ("rsus") issued pursuant to the haemonetics corporation 2019 long-term incentive compensation plan. the rsus vest in annual increments of 25% beginning on the first anniversary of the date of grant. |
f2 | each rsu represents a contingent right to receive one (1) share of the issuer's common stock when vested. |
f3 | option vests in annual increments of 25% beginning on the first anniversary of the date of grant. |